SUSAN BLAKEMORE: Open Payments
NPI 1437583390 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 23 payments from 7 companies in 2025. Trend: 2023 $452 · 2024 $391 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $201 |
| Lilly USA, LLC | 1 | $85 |
| Abbott Laboratories | 3 | $65 |
| Exact Sciences Corporation | 3 | $53 |
| Dexcom, Inc. | 2 | $37 |
| Medtronic, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: Ozempic, ZEPBOUND, FREESTYLE LIBRE 3, Cologuard Collection Kit, Dexcom G6 Transmitter, Rybelsus, INTELLIS ADAPTIVESTIM, GARDASIL 9.
Industry payments across IN — which companies pay providers there.
